ENTA
ENANTA PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$10.65
+2.70%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5.10x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.07x
- Price / sales
- 4.75x
- Price / cash flow
- -8.78x
Enterprise value
- Enterprise value
- $176.3M
- EV / sales
- 2.70x
- EV / EBITDA
- -3.89x
- EV / EBIT
- -3.00x
- Market cap
- $310.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026